HDCN is divided into a FREE ZONE and a KEY ZONE. The latter is open only to paid subscribers. The FREE ZONE is open to all who have registered and contains symposia where sponsorship of a professional society or company was obtained to defray costs of preparation, storage, and file transfer charges. Currently the FREE ZONE symposia on HDCN are as follows:
New Perspectives on the Progression of Coronary Artery Calcification and Patient Outcomes in Chronic Kidney Disease Wajeh Qunibi, MD, FACP and Lynda Szczech, MD, MSCE
(ANNA National Symposium, April, 2008.)
Achieving Control: Optimizing the Management of CKD-Anemia Allen R. Nissenson, MD; Steven Fishbane, MD; Michael J. Germain, MD; Robert Provenzano, MD
(CME Symposium (Synermed-Penn State), March, 2008.)
Management of Hyperphosphatemia in Patients with ESRD: A New Direction for Treatment in 2008 Wajeh Qunibi, MD, and Charles Nolan, MD
(CME Symposium (Medical Education Resources), January, 2008.)
Medical Crossfire: Managing Phosphorus in CKD -- The Challenge Remains David Bushinsky, MD (moderator); Geoffrey Block, MD, CCRI; Francisco Llach, MD; Rajnish Mehrotra, MD, FACP, FASN. (Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007)
Phosphate Binders in CKD: An Update on Treatment Outcomes and Future Directions Gérard M. London, MD (moderator); Craig B. Langman, MD; Markus Ketteler, MD. (Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007)
Challenges in Volume Management. Optimizing Care in Patients with Heart Failure and Renal Dysfunction John C. Burnett, MD; Michael B. Fowler, MBBS, FRCP, FACC; Mihai Gheorghiade, MD. (Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007)
Contrast Media and CKD: What You Should Know About Contrast-Induced Nephropathy and Nephrogenic Systemic Fibrosis Norbert Lameire, MD (moderator); Pontus B. Persson, MD, PhD; Michael V. Knopp, MD, PhD; Mark A. Perazella, MD (Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007)
New Developments in Anemia Management in Chronic Kidney Disease Dr. Adeera Levin, MD (moderator): Cindy Roy, PhD; Anatole Besarab, MD; Richard Amerling, MD, Arnold Berns, MD (discussant). (Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007)
Navigating the Erythropoietin Stimulating Agent Landscape in CKD-Related Anemia Jeffrey S. Berns, MD, FASN; Robert Provenzano, MD; Lynda Szczech, MD. (Moderator: Jeffrey S. Berns, MD) (Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007)
Chronic Kidney Disease - Mineral Bone Disorder (Jose A.L. Arruda, MD, FACP; Jennifer L. Snavely, CRNP-BC, MSN, CNN) Target audience: Nurses. ANNA National Symposium, April 2007)
Standards: The Basis of Care to Manage the Patient with Complications of Chronic Kidney Disease Leading to Cardiovascular Disease Sally Burrows-Hudson, MS, RN, CNN; Carol Headley, DNSc, RN, CNN; Sally Campoy, DNP(c), MS, APRN, BC. (Target audience: Nurses. ANNA National Symposium, April 2007)
Achieving and Maintaining a Phosphate Balance in the Patient With CKD. Terran Mathers, DNS, RN. (Target audience: Nurses. ANNA National Symposium, April 2007)
Early Anemia Management: Incorporating New Evidence Into Appropriate Treatment Strategies for Chronic Kidney Disease. Jay B. Wish, MD; William M. McClellan, Jr, MD; Richard A Lafayette, MD. (RPA Satellite Symposium, March, 2007).
Iron Deficiency Anemia in Various Patient Populations. Iron Management Considerations. Joanna Hudson, PharmD. (Target audience - Pharmacists. Medical Education Resources. February, 2007).